FDA classifies LivaNova’s recall of LifeSPARC system’s controller as Class I
The US health regulator claimed that the device could reach critical failure mode due to a problem in…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
30 Jan 23
The US health regulator claimed that the device could reach critical failure mode due to a problem in…
25 Jan 23
Hospitals in the US can now use Etiometry’s IDO2 Index to quickly identify changes in the conditions of…
25 Jan 23
The extended VADER Pedicle System maintains its proven indication and versatility for open, MIS and cement-augmented surgical techniques…
20 Jan 23
The FDA’s initial approval for the cardiac radioablation trial has been given for 80 patients at 10 US…
18 Jan 23
The company's latest-generation Navitor device has some upgrades to improve patient care, including reducing or eliminating the risk…
12 Jan 23
With the latest approval, the Swiss medical technology firm will start its clinical trial for which the enrolment…
11 Jan 23
The OncobiotaLUNG assay is the first blood microbiome-driven liquid biopsy with proven effectiveness, including identifying cancer in its…
10 Jan 23
The device uses the firm’s proprietary machine-learning technology to noninvasively diagnose organ dysfunction caused by inadequate cellular oxygenation…
09 Jan 23
Prapela's stimulation pad could become available sooner as a new treatment option for preterm newborns experiencing apnea
05 Jan 23
Newest Addition to Company’s Zoom Stroke Solution Provides an Additional Option for Achieving Intracranial Access to Treat Patients…